Targeting Bruton’s Tyrosine Kinase (BTK) in Autoimmunity: Achievements, Opportunities and Challenges
Drug Design, Development and Therapy · 2026-07 · Volume 20 · 1-16
DOI: 10.2147/dddt.s568214 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-07. Verfasst von Sebastian Torke und 2 weiteren Autor:innen. Beteiligte Einrichtung: Experimental and Clinical Research Center, Charité-Medical Center Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany. Hauptthemen laut MEDLINE: Agammaglobulinaemia Tyrosine Kinase, Autoimmune Diseases, Protein Kinase Inhibitors, Autoimmunity. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental and Clinical Research Center, Charité-Medical Center Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
- Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
- Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Translational Neuroinflammation and Automated Microscopy TNM, Göttingen, Germany.
ORCID-Profile: Sebastian Torke, Sarah Dybowski, Martin S Weber
Zitieren
APA
Torke, S., Dybowski, S., & Weber, M. S. (2026). Targeting Bruton’s Tyrosine Kinase (BTK) in Autoimmunity: Achievements, Opportunities and Challenges. Drug Design, Development and Therapy, Volume 20, 1-16. https://doi.org/10.2147/dddt.s568214
Vancouver
Torke S, Dybowski S, Weber MS. Targeting Bruton’s Tyrosine Kinase (BTK) in Autoimmunity: Achievements, Opportunities and Challenges. Drug Design, Development and Therapy. 2026;Volume 20:1-16. doi:10.2147/dddt.s568214
BibTeX
@article{Torke2026,
author = {Torke, Sebastian and Dybowski, Sarah and Weber, Martin S},
title = {Targeting Bruton’s Tyrosine Kinase (BTK) in Autoimmunity: Achievements, Opportunities and Challenges},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--16},
doi = {10.2147/dddt.s568214}
}
EUVIMED